<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.6//EN" "ep-patent-document-v1-6.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP18154812B8W1" file="EP18154812W1B8.xml" lang="en" country="EP" doc-number="3339861" kind="B8" correction-code="W1" date-publ="20231101" status="c" dtd-version="ep-patent-document-v1-6">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B005EP>J</B005EP><B007EP>BDM Ver 2.0.24 -  2999001/0</B007EP></eptags></B000><B100><B110>3339861</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20231101</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>18154812.4</B210><B220><date>20130613</date></B220><B240><B241><date>20181219</date></B241><B242><date>20190702</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>P1200368</B310><B320><date>20120615</date></B320><B330><ctry>HU</ctry></B330><B310>201261699193 P</B310><B320><date>20120910</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20231101</date><bnum>202344</bnum></B405><B430><date>20180627</date><bnum>201826</bnum></B430><B450><date>20230927</date><bnum>202339</bnum></B450><B452EP><date>20230414</date></B452EP><B480><date>20231101</date><bnum>202344</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>G01N  33/53        20060101AFI20180322BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C12Q   1/00        20060101ALI20180322BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>G01N  33/68        20060101ALI20180322BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>G01N  33/689       20130101 FI20141024BHEP        </text></classification-cpc><classification-cpc sequence="2"><text>G01N2800/368       20130101 LA20141006BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>BIOMARKERTEST ZUR VORHERSAGE ODER FRÜHERKENNUNG VON PRÄEKLAMPSIE</B542><B541>en</B541><B542>BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA</B542><B541>fr</B541><B542>BIOMARQUEURS UTILISÉS POUR PRÉDIRE OU DÉTECTER PRÉCOCEMENT LA PRÉ-ÉCLAMPSIE</B542></B540><B560><B561><text>WO-A1-2009/108073</text></B561><B561><text>JP-A- 2008 241 704</text></B561><B561><text>US-A1- 2008 261 253</text></B561><B562><text>LOCKWOOD C J; PAIDAS M J; LAPINSKI R; TAYLOR R: "Elevated maternal plasma beta-2-glycoprotein-1 (B2GP1) values precede the clinical onset of preeclampsia", AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY1995, vol. 172, no. 1 part 2, 427, 1995, page 378, XP009504149,</text></B562><B562><text>LIU C ET AL: "Proteomic analysis of human serum for Finding pathogenic factors and potential biomarkers in preeclampsia", PLACENTA, W.B. SAUNDERS, GB, vol. 32, no. 2, 9 November 2010 (2010-11-09), pages 168-174, XP028360520, ISSN: 0143-4004, DOI: 10.1016/J.PLACENTA.2010.11.007 [retrieved on 2010-11-17]</text></B562><B562><text>AUER J ET AL: "Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology", JOURNAL OF PROTEOMICS, ELSEVIER, AMSTERDAM, NL, vol. 73, no. 5, 10 March 2010 (2010-03-10) , pages 1004-1017, XP026929961, ISSN: 1874-3919, DOI: 10.1016/J.JPROT.2009.12.014 [retrieved on 2010-01-14]</text></B562><B562><text>SCHOLL P F ET AL: "Maternal serum proteome changes between the first and third trimester of pregnancy in rural Southern Nepal", PLACENTA, W.B. SAUNDERS, GB, vol. 33, no. 5, 8 February 2012 (2012-02-08), pages 424-432, XP028478163, ISSN: 0143-4004, DOI: 10.1016/J.PLACENTA.2012.02.009 [retrieved on 2012-02-15]</text></B562><B562><text>T. VÁRKONYI ET AL: "Microarray Profiling Reveals That Placental Transcriptomes of Early-onset HELLP Syndrome and Preeclampsia Are Similar", PLACENTA, vol. 32, 1 February 2011 (2011-02-01), pages S21-S29, XP055217224, ISSN: 0143-4004, DOI: 10.1016/j.placenta.2010.04.014</text></B562><B562><text>NANDOR GABOR THAN ET AL: "Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia", FRONTIERS IN IMMUNOLOGY, vol. 9, 8 August 2018 (2018-08-08), XP055724102, DOI: 10.3389/fimmu.2018.01661</text></B562><B562><text>TROND M. MICHELSEN ET AL: "The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4-vessel sampling", THE FASEB JOURNAL, vol. 33, no. 2, 18 October 2018 (2018-10-18), pages 2944-2956, XP055725694, US ISSN: 0892-6638, DOI: 10.1096/fj.201801193R</text></B562></B560></B500><B600><B620><parent><pdoc><dnum><anum>16186083.8</anum><pnum>3182126</pnum></dnum><date>20160829</date></pdoc><pdoc><dnum><anum>13803743.7</anum><pnum>2861989</pnum></dnum><date>20130613</date></pdoc></parent></B620></B600><B700><B720><B721><snm>THAN, Nandor</snm><adr><str>2033 Lennon Street</str><city>Grosse Pointe, MI 48236-1616</city><ctry>US</ctry></adr></B721><B721><snm>TARCA, Adi, L.</snm><adr><str>49225 Rockerfeller Drive</str><city>Canton, MI 48188</city><ctry>US</ctry></adr></B721><B721><snm>JUHÁSZ, Gábor</snm><adr><str>1/c Pázmány Péter Sétány</str><city>1117 Budapest</city><ctry>HU</ctry></adr></B721><B721><snm>KÉKESI, Adrienna, Katalin</snm><adr><str>Pázmány Péter Sétány 1/c</str><city>1117 Budapest</city><ctry>HU</ctry></adr></B721><B721><snm>MEIRI, Hamutal</snm><adr><str>12 Barasani St. 
Suite 48</str><city>69121 Tel Aviv</city><ctry>IL</ctry></adr></B721><B721><snm>PAPP, Zoltán</snm><adr><str>Kútvölgyi út 4.</str><city>1125 Budapest</city><ctry>HU</ctry></adr></B721><B721><snm>ROMERO, Roberto</snm><adr><str>3990 John R. 4 Brush Office 4734</str><city>Detroit, MI 48201</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Genesis Theranostix Korlatolt Felelossegu Tarsasag</snm><iid>102011536</iid><irf>01774</irf><adr><str>Andrássy út 18., 1. em. 9. ajtó</str><city>1061 Budapest</city><ctry>HU</ctry></adr></B731><B731><snm>Semmelweis University</snm><iid>101233895</iid><irf>01774</irf><adr><str>Üllöi út 26.</str><city>1085 Budapest</city><ctry>HU</ctry></adr></B731><B731><snm>The United States of America, As Represented by 
the Secretary, Dept. of Health &amp; Human Services 
Office of Technology Transfer</snm><iid>101478386</iid><irf>01774</irf><adr><str>National Institutes of Health 
6011 Executive boulevard 
Suite 325, MSC 7760</str><city>Bethesda, MD 20892-7660</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Lengyel, Zsolt</snm><iid>101095177</iid><adr><str>Danubia 
Patent &amp; Law Office LLC 
Bajcsy-Zsilinszky út 16</str><city>1051 Budapest</city><ctry>HU</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840></B800></SDOBI>
</ep-patent-document>
